Effects of prostacyclin during cardiopulmonary bypass in man.
D000328:Adult; D000368:Aged; D000990:Antithrombin III / Q000032:analysis; D001927:Brain Diseases / Q000517:prevention & control; D002315:Cardiopulmonary Bypass / Q000009:adverse effects*; D001026:Coronary Artery Bypass / Q000009:adverse effects; D011464:Epoprostenol / Q000627:therapeutic use*; D005260:Female; D005344:Fibrinopeptide A / Q000032:analysis; D006350:Heart Valve Prosthesis / Q000009:adverse effects; D006470:Hemorrhage / Q000517:prevention & control; D006801:Humans; D008297:Male; D008875:Middle Aged; D010974:Platelet Aggregation / Q000187:drug effects; D010976:Platelet Count; D011183:Postoperative Complications / Q000517:prevention & control*; D011453:Prostaglandins / Q000627:therapeutic use*
D011453:Prostaglandins; D005344:Fibrinopeptide A; D000990:Antithrombin III; D011464:Epoprostenol